tiprankstipranks
Trending News
More News >
Intellia Therapeutics (DE:38I)
FRANKFURT:38I

Compare Intellia Therapeutics (38I) vs. Competitors

Compare
13 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Intellia Therapeutics
€12.38
€1.36B
-3.19
15.38%
8 Buy
10 Hold
1 Sell
Moderate Buy
Kura Oncology
$8.57
$745.74M
-3.46
7.39%
9 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.19
$1.10B
-13.53
133.58%
8 Buy
0 Hold
0 Sell
Strong Buy
AbCellera Biologics
$4.14
$1.24B
-7.18
18.97%
4 Buy
1 Hold
0 Sell
Strong Buy
Janux Therapeutics Inc
$14.64
$880.56M
-8.74
-66.81%
14 Buy
2 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.42
$899.52M
-7.36
41.49%
8 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:38I
Intellia Therapeutics
12.38
2.56
26.12%
KURA
Kura Oncology
8.57
0.80
10.30%
CMPX
Compass Therapeutics
6.19
2.97
92.24%
ABCL
AbCellera Biologics
4.14
0.84
25.45%
JANX
Janux Therapeutics Inc
14.64
-27.24
-65.04%
BCAX
Bicara Therapeutics Inc.
16.42
4.44
37.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts